Bullish
Evotec Receives Grants to Advance Tuberculosis Treatment
Evotec SE has received two new grants from the Gates Foundation, totaling $9.9 million, to accelerate the discovery and development of novel tuberculo...
EVO
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (2)
Neutral (1)
Bearish (0)
Latest EVO News
Bullish
Bullish
Evotec SE stock (DE0005664809): Why does its drug discovery partnership model matter more now?
Evotec SE, a German biotech firm, utilizes an asset-light drug discovery partnership model with major pharmaceutical companies, focusing on early-stag...
Neutral
Evotec Nominates Dieter Weinand as Supervisory Board Chairman
Evotec SE has announced the nomination of Dieter Weinand as the Chairman of its Supervisory Board, with his election proposed for the June 11, 2026, A...
Research EVO on:
Ad Space